News Focus
News Focus
Followers 45
Posts 5349
Boards Moderated 1
Alias Born 05/04/2005

Re: None

Sunday, 06/21/2020 8:35:30 AM

Sunday, June 21, 2020 8:35:30 AM

Post# of 1768
Read the 10Q put out BY THE COMPANY, that has to filed with the SEC don't listen to me or pumpers

https://evokepharmainc.gcs-web.com/static-files/fff79429-f310-4a4d-b722-8f4d46e3a1d8


Especially the portion about "on going concern"

Going Concern
The Company has incurred recurring losses and negative cash flows from operations since inception and expects to continue to incur net losses for the foreseeable future until such time, if ever, that it can generate significant revenues from the sale of Gimoti. Although the Company had approximately $4.1 million in cash and cash equivalents at March 31, 2020, the Company anticipates that it will continue to incur losses from operations due to pre-approval and pre-commercialization activities, including interactions with FDA on the Company’s NDA resubmission for Gimoti, potentially manufacturing commercial batches of Gimoti, and general and administrative costs to support operations. As a result, the Company believes that there is substantial doubt
about its ability to continue as a going concern for one year after the date these financial statements are issued. The financial statements do not include any adjustments that may result from the outcome of this uncertainty.

All posts are In my opinion, and are not meant to harm or defame anyone, please do your own DD. Please click on my Favorite Links, Journey to the Edge of the Universe & tell me what you think.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent EVOK News